Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Alembic Ltd.

Price on BSE   24 Feb,15:28 LIVE
92.18
-2.41
(-2.55%)

© 2026 Rediff.com
  • Volume :
  • 14,481.00
  • Prev Close :
  • 94.59
  • Day's H/L (Rs.) :
  • 94.00 - 91.73
  • 52wk H/L (Rs.) :
  • 125.70 - 85.55
  • Mkt Cap (Rs. Cr) :
  • 2,367.19
Price on NSE   25 Feb,09:58 LIVE
92.80
+0.33
(+0.36%)

© 2026 Rediff.com
  • Volume :
  • 30,019.00
  • Prev Close :
  • 92.47
  • Day's H/L (Rs.) :
  • 93.74 - 92.50
  • 52wk H/L (Rs.) :
  • 125.54 - 85.46
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - Alembic Ltd.
PE Ratios
16.68
EPS (Rs.)
5.53
Sales (Rs. Cr)
72.28
Face Value (Rs.)
2
Net Profit Margin(%)
66.21
Last Bonus
1:1
Last Dividend(%)
120
Return on Average Equity
16.63

News for Alembic Ltd.

Alembic Pharma USFDA Nod for Generic Anti-Fungal
Alembic Pharma gets USFDA approval to market generic Efinaconazole Topical Solution (10%) for fungal infections. Market size estimated at USD 500 million.
Feb 24, 2026 18:25
Alembic Pharma Gets USFDA Nod for Parkinson's Drug
Alembic Pharmaceuticals receives USFDA approval for generic Carbidopa, Levodopa, and Entacapone tablets to treat Parkinson's disease.
Feb 06, 2026 13:02
Alembic Pharma Gets USFDA Nod for Eye Treatment
Alembic Pharmaceuticals receives USFDA approval for generic Difluprednate ophthalmic emulsion to treat eye inflammation and pain after surgery.
Jan 27, 2026 13:34
Alembic Gets USFDA Nod for Cancer Drug
Alembic Pharmaceuticals receives USFDA tentative approval for generic Bosutinib tablets, a cancer treatment drug. ANDA approval details inside.
Jan 12, 2026 13:34
Alembic Pharma Gets USFDA Nod for Eye Treatment
Alembic Pharmaceuticals receives USFDA approval for generic Loteprednol Etabonate & Tobramycin ophthalmic suspension for eye infections.
Dec 11, 2025 12:34

More News for Alembic Ltd. »

News for Pharmaceuticals and health care

Sensex, Nifty Rebound: Market Jumps in Early Trade
Sensex and Nifty rebound in early trade, driven by IT stocks and positive global cues. Key gainers and losers, FII/DII activity.
Feb 25, 2026 09:52
Bajaj Warns of EV Policy Failure in Maharashtra
Rajiv Bajaj criticizes Maharashtra's EV policy, Aaditya Thackeray blames BJP for its collapse. Subsidies slowed dramatically.
Feb 25, 2026 00:20
UP Invest Roadshow in Singapore: Adityanath Outlines Plans
Yogi Adityanath showcases Uttar Pradesh's investment potential at Invest UP Mega Road Show in Singapore, aiming for a $1 trillion economy.
Feb 24, 2026 22:49
Jewellery Retail Revenue to Rise 18% in FY27: Report
Jewellery retail sector projected to post 18% revenue growth in FY27 due to rising bullion prices. Read the full report.
Feb 24, 2026 22:36
AI Data Portal for Biotech Launched
Jitendra Singh launches SUJVIKA, an AI-driven data portal for biotech products. Insights into imports, R&D, and biomanufacturing.
Feb 24, 2026 22:27

More News »

Top News

Sensex, Nifty Rebound: Market Jumps in Early Trade
Sensex and Nifty rebound in early trade, driven by IT stocks and positive global cues. Key gainers and losers, FII/DII activity.
Feb 25, 2026 09:52
Bajaj Warns of EV Policy Failure in Maharashtra
Rajiv Bajaj criticizes Maharashtra's EV policy, Aaditya Thackeray blames BJP for its collapse. Subsidies slowed dramatically.
Feb 25, 2026 00:20
UP Invest Roadshow in Singapore: Adityanath Outlines Plans
Yogi Adityanath showcases Uttar Pradesh's investment potential at Invest UP Mega Road Show in Singapore, aiming for a $1 trillion economy.
Feb 24, 2026 22:49
Jewellery Retail Revenue to Rise 18% in FY27: Report
Jewellery retail sector projected to post 18% revenue growth in FY27 due to rising bullion prices. Read the full report.
Feb 24, 2026 22:36
AI Data Portal for Biotech Launched
Jitendra Singh launches SUJVIKA, an AI-driven data portal for biotech products. Insights into imports, R&D, and biomanufacturing.
Feb 24, 2026 22:27

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com